Repository of Research and Investigative Information

Repository of Research and Investigative Information

Baqiyatallah University of Medical Sciences

Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)?

(2021) Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19)? Clin Hypertens. p. 7.

[img] Text
Should all patients with hypertension be worried about developing severe coronavirus disease 2019 (COVID-19).pdf

Download (502kB)

Official URL: http://apps.webofknowledge.com/InboundService.do?F...

Abstract

Background Hypertension, the most common comorbidity among coronavirus disease 2019 (COVID-19) patients, is accompanied by worse clinical outcomes, but there is lack of evidence about prognostic factors among COVID-19 patients with hypertension. We have come up with some prognostic factors to predict the severity of COVID-19 among hypertensive patients. In addition, epidemiologic, clinical and laboratory differences among COVID-19 patients with and without underlying hypertension were evaluated. Methods Medical profiles of 598 COVID-19 cases were analyzed. Patients were divided into two comparative groups according to their positive or negative history of hypertension. Then, epidemiologic, clinical, laboratory and radiological features and also clinical outcomes were compared. Results 176 (29.4) patients had underlying hypertension. Diabetes was significantly higher in hypertensive group 72 (40.9%) vs 76 (18%) (P-value: 0.001). Cardiovascular and renal disorders were significantly higher in hypertensive patients. (P-value: 0.001 and 0.013 respectively). In COVID-19 patients with hypertension, severe/critical types were significantly higher. 42(23.8%) vs. 41(9.7%), (P-value: 0.012). In the logistic regression model, Body mass index > 25 (ORAdj: 1.8, 95% CI: 1.2 to 2.42; P-value: 0.027), age over 60 (ORAdj: 1.26, 95% CI: 1.08 to 1.42; P-value: 0.021), increased hospitalization period (ORAdj: 2.1, 95% CI: 1.24 to 2.97; P-value: 0.013), type 2 diabetes (ORAdj: 2.22, 95% CI: 1.15 to 3.31; P-value: 0.001) and chronic kidney disease (ORAdj: 1.83, 95% CI: 1.19 to 2.21; P-value: 0.013) were related with progression of COVID-19. Conclusion Hypertensive patients with Age > 60-year-old, BMI > 25 Kg/m(2), CVD, diabetes and chronic kidney disease are associated with poor outcomes in those with COVID-19 infection.

Item Type: Article
Keywords: Hypertension Risk factor Severe COVID-19 pneumonia Cardiovascular System & Cardiology
Page Range: p. 7
Journal or Publication Title: Clin Hypertens
Journal Index: ISI
Volume: 27
Number: 1
Identification Number: https://doi.org/10.1186/s40885-021-00161-7
Depositing User: مهندس مهدی شریفی
URI: http://eprints.bmsu.ac.ir/id/eprint/9544

Actions (login required)

View Item View Item